The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
The last decade has seen a radical change in our assumptions about the best ways to lower cardiovascular risk in patients with type 2 diabetes mellitus. In the past, considerable emphasis was placed on reduction of plasma glucose as the key to lowering cardiovascular risk and there were misplaced perceptions of benefit from aspirin in all patients. There is now overwhelming evidence that lowering...
The last decade has seen a paradigm shift in our understanding of the best mechanisms to lower cardiovascular risk in patients with type 2 diabetes. In the past, considerable emphasis was placed on reduction of plasma glucose as a key mechanism to lowering cardiovascular risk and there were misplaced perceptions of benefit from aspirin in all patients. There is now overwhelming evidence that lowering...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.